Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22081 |
FBPase-1 inhibitor-1
Fructose 1,6-bisphosphatase-1 Inhibitor |
Others | Others |
FBPase-1 inhibitor-1 (Fructose 1,6-bisphosphatase-1 Inhibitor) 是一种fructose-1,6-bisphosphatase (FBPase-1)的变构抑制剂。 | |||
T60312 |
FBPase-IN-1
|
||
FBPase-IN-1 is a powerful inhibitor of Fructose-1,6-bisphosphatase (FBPase), a key enzyme involved in Type 2 diabetes (T2D) research. It exhibits an impressive IC50 value of 0.22 μM. Aside from its potency, FBPase-IN-1 also demonstrates the ability to effectively lower blood glucose levels and improve glucose tolerance. Its mechanism of action involves covalently modifying the C128 site, thereby influencing the N125-S124-S123 allosteric pathway of FBPase, ultimately impacting its catalytic activ... | |||
T60294 | FBPase-IN-2 | ||
FBPase-IN-2 (HS36) 是一种有效的果糖-1,6-二磷酸酶 (FBPase) 共价抑制剂,IC50值为 0.15 μM。FBPase-IN-2 可减少肝细胞内葡萄糖的产生,可用于二型糖尿病的研究。 | |||
T16009L |
Managlinat dialanetil
MB06322,MB 6322,CS-917 |
Phosphatase | Metabolism |
Managlinat dialanetil (MB06322) 是一种可口服且具有有效性的 fructose 1,6-bisphosphatase (FBPase) 抑制剂,具有降糖活性,可用于研究 2 型糖尿病。 | |||
T16020 | MB05032 | Others | Others |
MB05032 targeted the AMP binding site of fructose 1,6-bisphosphatase (FBPase), which is a special and efficacious inhibitor of GNG. | |||
T16017 |
MB-07803
|
Others | Others |
MB07803 is an orally available prodrug of an effective, noncompetitive inhibitor of fructose 1,6-bisphosphatase (FBPase) (EC50: 140 nM and t1/2 of 7.6±2.9 h). | |||
T16009 |
(Rac)-Managlinat dialanetil
CS-917,(Rac)-MB06322,MB06322,(Rac)-CS-917 |
Others; DHFR | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism; Others |
(Rac)-Managlinat dialanetil ((Rac)-MB06322) 是 Managlinat dialanetil 的外消旋体,Managlinat dialanetil 是一种可口服且具有有效性的 fructose 1,6-bisphosphatase (FBPase) 抑制剂,可用于研究 2 型糖尿病。 |